Mode
Text Size
Log in / Sign up
N/A N=120 Randomized Treatment

Multimodal Sleep Intervention Using Wearable Technology

Drinking, Alcohol

Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcome: Primary: Total Alcohol Drinks Consumed Over the 12wk Followup — 3.07; 2.95; 2.96 log-transformed total alcohol drinks — p=0.75

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Advice (Behavioral); Self-monitoring (Behavioral); Feedback (Behavioral)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Yale University
Primary completion
Dec 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Total Alcohol Drinks Consumed Over the 12wk Followup
3.07; 2.95; 2.96 0.75
SECONDARY
National Institutes of Health Patient-Reported Outcomes Measurement Information System™ (NIH PROMIS™) Sleep Disturbance Score- Least Squares Mean Across Assessments
51.39; 49.75; 49.46 0.05
SECONDARY
National Institutes of Health Patient-Reported Outcomes Measurement Information System™ (NIH PROMIS™) Sleep-Related Impairment Score - Least Squares Mean Across Assessments
57.80; 57.05; 54.89 0.02 sig
SECONDARY
End of Treatment Satisfaction Survey Score
3.45; 3.48; 3.60

Summary

This research study is examining three different components of a digital sleep intervention: web-based sleep health advice, sleep and alcohol smartphone diary self-monitoring, and personalized sleep and alcohol consumption feedback from wearables/diaries and tailored coaching. The study is designed to find out which of these components are most effective for reducing alcohol use and improving sleep health among young adults. The study has three parts: 1) an intake session; 2) a 2-week treatment phase; and 3) three follow-up visits over the next 10 weeks.

Eligibility Criteria

Inclusion Criteria

  • 18-25 years of age;
  • report ≥ 3 heavy drinking occasions in the last 2 weeks (i.e., ≥5 drinks on 1 occasion for men; ≥4 for women);
  • report having concerns about their sleep;
  • willing/able to complete daily smartphone diaries and wear sleep and alcohol trackers;
  • report Alcohol Use Disorders Identification Test - Consumption (AUDIT-C) scores indicative of risk of harm from drinking (i.e., ≥7 and ≥5 for men and women, respectively)
  • read and understand English;
  • have a smartphone

Exclusion Criteria

  • history of a sleep disorder;
  • night or rotating shift work; travel beyond 2 time zones in month prior and/or planned travel beyond 2 time zones during study participation;
  • meet criteria for an alcohol use disorder in the past 12 months that is clinically severe defined by: a) a history of seizures, delirium, or hallucinations during alcohol withdrawal; b) report drinking to avoid withdrawal symptoms or have had prior treatment of alcohol withdrawal; c) have required medical treatment of alcohol withdrawal in the past 6 months;
  • currently enrolled in alcohol or sleep treatment;
  • exhibit current severe psychiatric illness (i.e., bipolar disorder, schizophrenia, major depression, panic disorder, organic mood or mental disorders, or suicide or violence risk) by history or psychological examination;
  • current DSM-V substance use disorder (other than cannabis) or a positive urine drug screen for opiates, cocaine, barbiturates, benzodiazepines, amphetamines, or phencyclidine.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03658954). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search